Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPollen Street Regulatory News (POLN)

Share Price Information for Pollen Street (POLN)

Share Price is delayed by 15 minutes
Get Live Data
833.00    -5.00 (-0.60%)
Bid:
834.00
Ask:
840.00
Spread: 6.00 (0.719%)
Market Cap: £495.24m
POLN Live PriceLast checked at - London Stock Exchange

Intraday Pollen Street Share Chart

Q1 2026 Trading Update

7 May 2026 07:00

RNS Number : 3122D
Pollen Street Group Limited
07 May 2026
 

7 May 2026

Pollen Street Group Limited: Q1 2026 Trading Update

Pollen Street Group Limited ("Pollen Street", together with its subsidiaries, the "Group") is pleased to publish its trading update for the quarter ended 31 March 2026.

Total AuM

·

Total AuM increased by £1.1 billion during the quarter, to £8.2 billion as of 31 March 2026 reflecting strong fundraising in Private Credit IV ahead of its final close.

·

Total AuM as of 31 March 2026 comprised £4.2 billion in Private Equity and £4.0 billion in Private Credit.

·

Private Credit IV held its final close in April at £2.5 billion, significantly exceeding the initial target. Following the final close, total AuM stood at £8.4 billion.

Fee-Paying AuM

·

Fee-paying AuM ("FP AuM") increased £0.2 billion to £5.4 billion as of 31 March 2026.

·

Private Equity FP AuM remained at £3.1 billion and Private Credit FP AuM grew to £2.3 billion, reflecting £0.2 billion of net deployment during the period.

·

At the quarter end, the Group had £1.7 billion of undeployed committed capital across Private Credit funds, which will become fee-paying as it is deployed over time.

Full year FY26 expectations for Net Investment Return for the Investment Company remain unchanged, notwithstanding volatile market conditions during the quarter.

About Pollen Street

Pollen Street is an alternative asset manager dedicated to investing within the financial and business services sectors across both Private Equity and Private Credit strategies. The business was founded in 2013 and has consistently delivered top tier returns alongside growing AuM.

 

Pollen Street benefits from a complementary set of asset management activities focused on managing third-party AuM (the "Asset Manager") together with on-balance sheet investments (the "Investment Company").

 

The Asset Manager raises capital from high quality investors and deploys it into its Private Equity and Private Credit strategies. The strong recurring revenues from this business enable delivery of scalable growth.

 

The Investment Company invests in the strategies of the group delivering attractive risk adjusted returns and accelerating growth in third-party AuM of the Asset Manager through investing in Pollen Street funds, taking advantage of attractive investment opportunities and aligning interest with our investors to grow AuM. Today the portfolio is largely invested in credit assets with the allocation to Private Equity expected to increase to 30 per cent in the long term. The portfolio consists of both direct investments and investments in funds managed by Pollen Street.

 

POLN is listed on the London Stock Exchange (ticker symbol: POLN) and is a member of the FTSE 250 index. Further details are available at www.pollenstreetgroup.com.

 

For further information about this announcement please contact:

 

Pollen Street - Corporate Development Director

Shweta Chugh

+44 (0)20 3965 5081

 

Barclays Bank plc - Joint Broker

Neal West

+44 (0)20 7623 2323

 

Investec Bank plc - Joint Broker

Ben Griffiths / Kamalini Hull

+44 (0)20 7597 4000

 

FGS Global

Chris Sibbald / Anna Tabor

PollenStreetCapital-LON@fgsglobal.com

 

LEI: 894500LP94M98N8CY487

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUNSNRNVUVRAR
Date   Source Headline
7th Oct 20245:21 pmRNSHolding(s) in Company
4th Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20242:06 pmRNSTotal Voting Rights
27th Sep 20247:00 amRNSTransaction in Own Shares
25th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20244:33 pmRNSInvestor Presentation via Investor Meet Company
19th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20243:33 pmRNSInterim Dividend Declaration
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSInterim Accounts H1 2024
2nd Sep 20243:19 pmRNSReplacement: Total Voting Rights
2nd Sep 202412:10 pmRNSTotal Voting Rights
29th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20249:37 amRNSTotal Voting Rights
11th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
2nd Jul 20247:00 amRNSTransaction in Own Shares
1st Jul 20243:09 pmRNSTotal Voting Rights
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSTransaction in Own Shares
25th Jun 20244:52 pmRNSHolding(s) in Company
25th Jun 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 20247:00 amRNSTransaction in Own Shares
17th Jun 20244:18 pmRNSHolding(s) in Company
14th Jun 20243:00 pmRNSResult of AGM
14th Jun 20242:42 pmRNSHolding(s) in Company
14th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20244:25 pmRNSTotal Voting Rights
21st May 20247:00 amRNSPosting of Notice of AGM
10th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20245:21 pmRNSDirector/PDMR Shareholding
3rd May 20247:00 amRNSTrading Statement
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20243:46 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSAnnual Financial Report
29th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 202411:34 amRNSInvestor Presentation via Investor Meet Company
5th Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20245:12 pmRNSDirector/PDMR Shareholding
25th Mar 20245:00 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAnnual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.